Auxogyn Receives $18,000,000 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b6f57de5-7c2e-4004-a8a9-a96d9093b6c1&Preview=1 -
Date
6/6/2012 -
Company Name
Auxogyn -
Mailing Address
1490 O’Brien Drive Menlo Park, CA 94025 -
Company Description
Auxogyn – Advancing women’s reproductive health through novel scientific and clinical knowledge of early human developmental biology. -
Website
http://www.auxogyn.com -
Transaction Type
Venture Equity -
Transaction Amount
$18,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The proceeds will be used to support regulatory clearance and commercial launch of Auxogyn’s Early Embryo Viability Assessment, Eeva, a non-invasive test designed to provide objective information regarding the viability of embryos during in vitro fertilization (IVF) procedures. -
M&A Terms
-
Venture Investor
SR One -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
TPG Biotech -
Venture Investor
Merck Serono Ventures
